PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
14.87%
Net income growth above 1.5x BB's 7.90%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
213.92%
D&A growth well above BB's 28.62%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3688.24%
Well above BB's 85.10% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3688.24%
Growth well above BB's 85.10%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-303.27%
Both negative yoy, with BB at -49.62%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-2.72%
Negative yoy CFO while BB is 159.02%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-484.00%
Both yoy lines negative, with BB at -43.11%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-1117.37%
Negative yoy purchasing while BB stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
No Data
No Data available this quarter, please select a different quarter.
2538.54%
Growth of 2538.54% while BB is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
4.70%
We have mild expansions while BB is negative at -2982.94%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-71.12%
Negative yoy issuance while BB is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-88.48%
We cut yoy buybacks while BB is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.